Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
L02BA03	FULVESTRANT EVER PHARMA	G	Fulvestrant - 250mg/5ml	250mg	Injectable solution	29,905,966 L.L
C03CA01	FUROSEMIDE RENAUDIN	G	Furosemide - 250mg/25ml	250mg/25ml	Injectable solution	1,791,342 L.L
C03CA01	FUROSEMIDE S.A.L.F.	G	Furosemide - 250mg/25ml	250mg/25ml	Injectable solution	919,188 L.L
L02BA03	FASLODEX	B	Fulvestrant - 250mg/5ml	250mg/5ml	Injectable solution	46,628,557 L.L
L02BA03	FULVESTRANT ARROW	G	Fulvestrant - 250mg/5ml	250mg/5ml	Injectable solution	12,644,009 L.L
L02BA03	FUXRAN	G	Fulvestrant - 250mg/5ml	250mg/5ml	Injectable solution	39,382,304 L.L
L02BA03	FASLODEX	B	Fulvestrant - 250mg/5ml	250mg/5ml	Injectable solution	L.L
A10BK03	FLORIANCE 25	G	Empagliflozin - 25mg	25mg	Tablet, film coated	1,791,790 L.L
N03AX22	FYCOMPA	B	Perampanel - 2mg	2mg	Tablet, film coated	1,138,235 L.L
R03DX10	FASENRA	B	Benralizumab - 30mg	30mg	Injectable solution	L.L
R03DX10	FASENRA	B	Benralizumab - 30mg	30mg	Injectable solution	214,213,273 L.L
A16AB04	FABRAZYME	BioTech	Agalsidase beta - 35mg	35mg	Injectable powder for concentrate for solution	L.L
A16AB04	FABRAZYME	BioTech	Agalsidase beta - 35mg	35mg	Injectable powder for concentrate for solution	295,038,213 L.L
J01XX01	FOSFOKEY	G	Fosfomycine (trométamol) - 3g	3g	Granules for solution	399,121 L.L
J01XX01	FOSFOLAG	G	Fosfomycine (trométamol) - 3g	3g	Granules for solution	399,121 L.L
S01AE01	FLOXIGEN	G	Ofloxacin - 3mg/ml	3mg/ml	Drops solution	358,806 L.L
S01AE01	FLOXEDOL	G	Ofloxacin - 3mg/ml	3mg/ml	Gel	339,992 L.L
J01MA14	FLOXIMOX	G	Moxifloxacin (HCl) - 400mg	400mg	Tablet, film coated	1,062,276 L.L
J01DD08	FIXIM	G	Cefixime (trihydrate) - 400mg	400mg	Capsule	1,435,224 L.L
A02BA03	FAMODAR 40	G	Famotidine - 40mg	40mg	Tablet, film coated	552,319 L.L
A02BA03	FAMONOR	G	Famotidine - 40mg	40mg	Tablet, film coated	439,436 L.L
C03CA01	FURESIX 40	G	Furosemide - 40mg	40mg	Tablet	166,381 L.L
C03CA01	FUROSETIC	G	Furosemide - 40mg	40mg	Tablet, scored	121,586 L.L
N03AX22	FYCOMPA	B	Perampanel - 4mg	4mg	Tablet, film coated	8,751,127 L.L
P01AB01	FLAGYL	B	Metronidazole - 500mg	500mg	Tablet, film coated	310,428 L.L
V03AE03	FOSRENOL	B	Lanthanum Carbonate - 500mg	500mg	Tablet, chewable	18,751,847 L.L
J01MA12	FLOBIOX	G	Levofloxacin - 500mg	500mg	Tablet, film coated	629,686 L.L
J01MA12	FLOBIOX	G	Levofloxacin - 500mg	500mg	Tablet, film coated	794,787 L.L
J01MA12	FLOXIN-L 500	G	Levofloxacin (hemihydrate) - 500mg	500mg	Tablet, film coated	831,903 L.L
N02BE01	FEBRADOL	G	Paracetamol - 500mg	500mg	Tablet	327,642 L.L